Patents by Inventor Guiying Li

Guiying Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclo[3.2.1]octyl amide derivatives and uses of same
    Patent number: 9656975
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: May 23, 2017
    Assignee: H. Lundbeck A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME
    Publication number: 20160326154
    Abstract: The present invention provides compounds of formula (I): where R1, R2, X, Y and n are as described herein, and pharmaceutical compositions, uses and methods comprising same.
    Type: Application
    Filed: December 11, 2015
    Publication date: November 10, 2016
    Applicant: H. Lundbeck A/S
    Inventors: Dario Doller, Guiying Li
  • Spirolactam derivatives and uses of same
    Patent number: 9359297
    Abstract: The present invention provides spirolactam derivatives of formula (I): wherein R1-R7 are as defined herein; or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and uses of the same.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: June 7, 2016
    Assignee: H. Lundbeck A/S
    Inventors: Hao Zhou, Guiying Li, Dario Doller, Gil Ma
  • Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same
    Patent number: 9212165
    Abstract: The present invention provides compounds of formula (I): where R1, R2, X, Y and n are as described herein, and pharmaceutical compositions, uses and methods comprising same.
    Type: Grant
    Filed: September 17, 2012
    Date of Patent: December 15, 2015
    Assignee: H. Lundbeck A/S
    Inventors: Dario Doller, Guiying Li
  • Standard capacitance box output device
    Patent number: 9208944
    Abstract: The invention discloses a capacitance standard box output device. The number of standard capacitors is reduced, so that the structure of a changeover switch is simplified, and the number of connection wires is reduced, so as to improve the shield effect and reduce uncertainty. The technical proposal of the invention is as follows: The capacitance standard box output device comprises a changeover switch and precision capacitors, wherein the changeover switch is placed in a shield box; the shield box has an input terminal and an output terminal; the input terminal is connected to the changeover switch and the precision capacitor; the output is connected to the changeover switch and outputs the capacitance selected by the changeover switch; the selected capacitance is a product of a unit capacitance and an arbitrary integer value between 0 and 10; the number of the precision capacitors is from 4 to 9, and at least one capacitor is of a unit capacitance.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: December 8, 2015
    Inventor: Guiying Li
  • BICYCLO[3.2.1.]OCTYL AMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20150057289
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: November 4, 2014
    Publication date: February 26, 2015
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • Bicyclo[3.2.1]octyl amide derivatives and uses of same
    Patent number: 8921370
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: December 30, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME
    Publication number: 20140350030
    Abstract: The present invention provides compounds of formula (I): where R1, R2, X, Y and n are as described herein, and pharmaceutical compositions, uses and methods comprising same.
    Type: Application
    Filed: September 17, 2012
    Publication date: November 27, 2014
    Inventors: Dario Doller, Guiying Li
  • SPIROLACTAM DERIVATIVES AND USES OF SAME
    Publication number: 20140194424
    Abstract: The present invention provides spirolactam derivatives of formula (I): wherein R1-R7 are as defined herein; or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and uses of the same.
    Type: Application
    Filed: December 12, 2013
    Publication date: July 10, 2014
    Inventors: Hao Zhou, Guiying Li, Dario Doller, Gil Ma
  • Adamantyl diamide derivatives and uses of same
    Patent number: 8716284
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: May 6, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Hermogenes N. Jimenez, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo
  • Spirolactam derivatives and uses of same
    Patent number: 8633190
    Abstract: The present invention provides spirolactam derivatives of formula (I): wherein R1-R7 are as defined herein; or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and uses of the same.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: January 21, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Hao Zhou, Guiying Li, Dario Doller, Gil Ma
  • Standard Capacitance Box Output Device
    Publication number: 20130223040
    Abstract: The invention discloses a capacitance standard box output device. The number of standard capacitors is reduced, so that the structure of a changeover switch is simplified, and the number of connection wires is reduced, so as to improve the shield effect and reduce uncertainty. The technical proposal of the invention is as follows: The capacitance standard box output device comprises a changeover switch and precision capacitors, wherein the changeover switch is placed in a shield box; the shield box has an input terminal and an output terminal; the input terminal is connected to the changeover switch and the precision capacitor; the output is connected to the changeover switch and outputs the capacitance selected by the changeover switch; the selected capacitance is a product of a unit capacitance and an arbitrary integer value between 0 and 10; the number of the precision capacitors is from 4 to 9, and at least one capacitor is of a unit capacitance.
    Type: Application
    Filed: October 26, 2011
    Publication date: August 29, 2013
    Inventor: Guiying Li
  • Adamantyl diamide derivatives and uses of same
    Patent number: 8389519
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: March 5, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Hermogenes N. Jimenez, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo
  • sp. for degrading tetrabromobisphenol-A (TBBPA) and its application
    Patent number: 8343750
    Abstract: The invention discloses an Ochrobactrum sp. for degrading TBBPA and its application in environmental remediation. An Ochrobactrum sp. for degrading TBBPA was isolated from the sludge in a high risk area of electronic waste in the invention. The strain is named as Ochrobactrum sp. T, which has been deposited in China Center for Type Culture Collection (CCTCC) on Oct. 28, 2009 with an accession number of CCTCC M209246. Ochrobactrum sp. T obtained in the invention has high degradation capability to TBBPA in environment. The degradation efficiency of the strain achieves 96.2%. The strain could be applied to degrading TBBPA in environmental remediation.
    Type: Grant
    Filed: December 30, 2009
    Date of Patent: January 1, 2013
    Assignee: Guangzhou Institute of Geochemistry, Chinese Academy of Science
    Inventors: Guiying Li, Taicheng An, Lei Zu
  • ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20120270873
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: May 15, 2012
    Publication date: October 25, 2012
    Applicant: H. Lundbeck A/S
    Inventors: Hermogenes N. JIMENEZ, Guiying LI, Dario DOLLER, Michel GRENON, Andrew D. WHITE, Gil MA, Maojun GUO
  • BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20120190686
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: December 22, 2011
    Publication date: July 26, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • Adamantyl diamide derivatives and uses of same
    Patent number: 8198275
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: June 12, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Hermogenes N. Jimenez, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo
  • OCHROBACTRUM SP. FOR DEGRADING TETRABROMOBISPHENOL-A (TBBPA) AND ITS APPLICATION
    Publication number: 20110281332
    Abstract: The invention discloses an Ochrobactrum sp. for degrading TBBPA and its application in environmental remediation. An Ochrobactrum sp. for degrading TBBPA was isolated from the sludge in a high risk area of electronic waste in the invention. The strain is named as Ochrobactrum sp. T, which has been deposited in China Center for Type Culture Collection (CCTCC) on Oct. 28, 2009 with an accession number of CCTCC M209246. Ochrobactrum sp. T obtained in the invention has high degradation capability to TBBPA in environment. The degradation efficiency of the strain achieves 96.2%. The strain could be applied to degrading TBBPA in environmental remediation.
    Type: Application
    Filed: December 30, 2009
    Publication date: November 17, 2011
    Applicant: Guangzhou Institute of Geochemistry, Chinese Academy of Sciences
    Inventors: Guiying Li, Taicheng An, Lei Zu
  • ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20110178086
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: March 30, 2011
    Publication date: July 21, 2011
    Applicant: H. Lundbeck A/S
    Inventors: Hermogenes N. Jimenez, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo
  • Adamantyl diamide derivatives and uses of same
    Patent number: 7947680
    Abstract: The present invention provides adamantyl-diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: May 24, 2011
    Assignee: H. Lundbeck A/S
    Inventors: Hermogenes N. Jimenez, Guiying Li, Dario Doller, Michel Grenon, Andrew D. White, Gil Ma, Maojun Guo